Abstract
Uncovering the risk factors of pulmonary hypertension and its mechanisms is crucial for the prevention and treatment of the disease. In the current study, we showed that experimental periodontitis, which was established by ligation of molars followed by orally smearing subgingival plaques from patients with periodontitis, exacerbated hypoxia-induced pulmonary hypertension in mice. Mechanistically, periodontitis dysregulated the pulmonary microbiota by promoting ectopic colonization and enrichment of oral bacteria in the lungs, contributing to pulmonary infiltration of interferon gamma positive (IFNγ+) T cells and aggravating the progression of pulmonary hypertension. In addition, we identified Prevotella zoogleoformans as the critical periodontitis-associated bacterium driving the exacerbation of pulmonary hypertension by periodontitis, and the exacerbation was potently ameliorated by both cervical lymph node excision and IFNγ neutralizing antibodies. Our study suggests a proof of concept that the combined prevention and treatment of periodontitis and pulmonary hypertension are necessary.
Subject terms: Periodontitis, Cardiovascular diseases
Introduction
Pulmonary hypertension (PH) remains a serious condition with a poor prognosis.1 PH is a progressive disease characterized by the gradual destruction of pulmonary arteries (PAs), elevated pulmonary arterial pressure, and hypertrophy and remodeling of the right ventricle (RV), culminating in RV failure and death.2 Common pathological features include remodeling of the distal PA and the infiltration of inflammatory cells.3 Limited treatment options for PH highlight the urgent need for more therapeutic targets.4
There is growing evidence suggesting that PH is a systemic disease influenced by the microbiota.5–10 Moreover, the role of the gut-lung axis in PH has garnered increasing attention.5,7 Numerous studies have explored the relationship between PH and the gastrointestinal tract, revealing a proinflammatory gut microbiota and altered microbial metabolites in individuals with PH.11–14 Furthermore, depletion of the gut microbiota through antibiotic intervention retards PH development in a rat model.15
On a different note, the significance of the oral-lung axis in respiratory diseases has gained prominence. Oral health status has been proposed to be a determinant of lung health because the microbes from the oral cavity can induce respiratory infections and inflammation after being inhaled into the lower respiratory tract.16–18 Additionally, associations have been observed between oral dysbiosis, notably periodontal disease, and various respiratory diseases.17,19,20 However, the specific role of the oral microbiota in maintaining lung homeostasis during PH remains largely unexplored.
Periodontitis serves as a paradigmatic illustration of oral microecological imbalance with epidemiological links to various systemic diseases, including respiratory infections.21 The interconnection between periodontitis and systemic comorbidities is often mediated through both local and systemic immune responses to oral pathogens.22 Moreover, substantial evidence indicates that inflammation plays a key role in human and experimental PH.23 Immune cell infiltration, which mainly involves T and B lymphocytes, macrophages, monocytes, mast cells and dendritic cells, is observed in remodeled pulmonary arteries in patients with PH.24,25 In addition, high levels of cytokines, chemokines and autoantibodies have been detected in animal models and patients with PH, suggesting local adaptive immune responses in the lung.25,26 Therefore, exploring the interaction between the oral microbiota and immunity in PH may offer novel therapeutic insights for managing PH.
Our primary goal in this study was to investigate the causal relationship between periodontitis and PH and to identify underlying mechanisms involved. First, we used a composite mouse model combining an experimental periodontitis model with hypoxia-induced PH to examine the impact of periodontitis on PH. Then, we conducted a comprehensive analysis of the oral and lung microbiota to identify the pivotal oral microbes involved in the influence of periodontitis on pathological progression of PH. Next, we explored the impacts of oral microbes on the immune response during PH. Finally, neutralizing antibodies were used to assess whether the immune response mediated the effect of oral microbes on exacerbating PH.
Results
Periodontitis exacerbates hypoxia-induced PH in mice
To explore the impact of periodontitis on the progression of PH in mice, we established a mouse periodontitis model by ligating the bilateral maxillary second molars with silk suture and smearing subgingival plaques derived from periodontitis patients for 2 weeks (the composite model was referred as PD). The mice were then subjected to 3 weeks of hypoxia to induce PH (Fig. 1a). As expected, periodontitis resulted in substantial alveolar bone loss in mice under normoxic and hypoxic conditions (Fig. S1a and S1b). Increased RV afterload is a result of elevated pulmonary circulation pressure, which eventually causes RV hypertrophy and dysfunction.27 Mice in the PH + PD group exhibited significant increases in right ventricular systolic pressure (RVSP) and Fulton index, two markers of RV hypertrophy, compared with mice in the PH group (Fig. 1b, c). However, periodontitis did not affect RVSP or Fulton index in mice without PH (Fig. 1b, c). A decrease in the pulmonary artery acceleration to ejection time (PAT/PET) ratio often indicates compromised pulmonary vascular function in PH mice. Echocardiography demonstrated a smaller PAT/PET ratio in PH + PD mice than in PH mice, but no difference was observed between PD mice and Ctrl mice (Fig. 1d, e). To evaluate cardiomyocyte hypertrophy of right ventricle, we carried out wheat germ agglutinin (WGA) staining of mouse heart sections. The results demonstrated a larger cardiomyocyte size in PH + PD mice compared with PH mice (Fig. 1f, g). In addition, hematoxylin and eosin (H&E) staining (Fig. 1h, i) and immunofluorescence staining of lung sections (Fig. 1j, k) respectively revealed significantly thickened medial walls and increased α-smooth muscle actin positive (α-SMA+) areas in distal PAs of PH + PD mice compared with PH mice, suggesting more severe vascular remodeling of pulmonary artery in PH + PD mice than that in PH mice. Collectively, our data showed that periodontitis exacerbated the progression of hypoxia-induced PH.
Periodontitis increases the accumulation of Prevotella zoogleoformans (P. zoogleoformans) in the oral cavity and lungs of mice with PH
Next, we utilized full-length 16 S rRNA gene sequencing to examine bacterial changes in the oral cavity and lungs of the mice. α-diversity analysis revealed increases in Chao1 richness, Faith phylogenetic diversity, and Observed species richness in oral ligatures and the lungs of PH + PD mice versus PH mice (Fig. 2a, b). Additionally, differences in bacterial composition between PH and PH + PD animals were observed by principal coordinate analysis based on Bray‒Curtis distances (Fig. 2c, d). Overall, the structural differences in bacterial communities were significant, categorizing the samples into distinct groups (PH and PH + PD). These data demonstrated that periodontitis markedly remodeled the bacterial ecology in the oral cavity and pulmonary niche in mice.
Moreover, microbial differences at the levels ranging from phylum to species were analyzed to determine whether there were bacterial taxa that were changed in a similar trend in the lungs and oral cavity in the presence of periodontitis. Intriguingly, P. zoogleoformans, the bacterial species that ranked the highest in the lungs, was also enriched in the oral cavity of PH + PD mice compared with PH mice, according to the random forest regression analysis (Fig. 2e, f). The Linear discriminant analysis effect size (LEfSe) consistently showed that 14 bacterial species including P. zoogleoformans were enriched in the oral cavity of the PH + PD group, while 5 bacterial species were enriched in the PH group (Fig. S2a and S2b). As shown by the relative abundance of species-level microbiota, P. zoogleoformans was significantly enriched in both oral cavity and lungs in the PH + PD group versus PH group (Fig. 2g, h, S2c and S2d). Furthermore, P. zoogleoformans was observed in the lung sections of PH + PD mice, but not in those of PH mice, indicating that it ectopically colonized in lungs after periodontitis induction (Fig. 2i). These findings altogether demonstrated that periodontitis promoted the dysregulation of the oral and lung microbiota and the accumulation of P. zoogleoformans in the lungs of PH mice.
P. zoogleoformans promotes the progression of PH in mice
To examine the contribution of P. zoogleoformans to the progression of PH, mice were either orally inoculated with P. zoogleoformans for 2 weeks or not, and then subjected to 3 weeks of hypoxic treatment (Fig. 3a). The combined treatment of P. zoogleoformans inoculation and ligation of molars (Pz) contributed to significant alveolar bone resorption, suggesting the successful modeling of periodontitis (Fig. S3a, S3b and S3c). RVSP and Fulton index were all significantly increased in PH + Pz mice versus PH mice, indicating that P. zoogleoformans worsened PH and right ventricular dysfunction in mice (Fig. 3b, c). Instead, Atopobium parvulum and Streptococcus mutans did not affect these parameters (Fig. S4a, S4b and S4c), suggesting the specific role of P. zoogleoformans in promoting PH. Echocardiography revealed a decrease in the PAT/PET ratio in PH + Pz mice (Fig. 3d, e). Consistently, PH + Pz mice exhibited a more pronounced increase in cardiomyocyte size and RV hypertrophy than PH mice (Fig. 3f, g). The histopathological examinations confirmed severe PH-associated vascular remodeling in PH + Pz mouse lungs, as evidenced by increases in wall thickness and α-SMA-positive areas of pulmonary arteries (Fig. 3h–j). Additionally, the results of fluorescence in situ hybridization demonstrated the presence of P. zoogleoformans in the lungs of PH + Pz mice, but not in those of PH mice (Fig. 3k). Put all these data together, it was indicated that oral inoculation of P. zoogleoformans potently aggravated hypoxia-induced PH.
P. zoogleoformans elevates the accumulation of interferon gamma (IFNγ)-producing T cells
Dysregulated immune response is a prominent pathological hallmark of PH, which is characterized by the overwhelming infiltration of immune cells including T lymphocytes into the pulmonary vasculature.28,29 To identify the underlying mechanisms by which P. zoogleoformans exacerbates PH, we focused on profiling immune cells in the lungs and cervical lymph nodes (cLNs) of both PH and PH + Pz mice 7 days after the hypoxia treatment using the flow cytometry. There was no significant change in the numbers of total CD4+ or CD8+ T cells between the PH + Pz and PH groups (Fig. S5a and S5b). However, the percentages and numbers of CD4+ IFNγ+ T cells and CD8+ IFNγ+ T cells, but not that of interleukin-17A positive (IL17A+) T cells, were notably increased in the lungs in the PH + Pz groups versus PH groups (Fig. 4a–d, S5c and S5d). In addition, oral inoculation of P. zoogleoformans significantly increased the numbers of CD4+ IFNγ+ T cells in cLNs, while their proportion remained unchanged (Fig. 4e, f). The numbers of CD8+ IFNγ+ T cells were comparable in cLNs between the PH and PH + Pz groups, indicating that the decrease of relative proportion of CD8+ IFNγ+ T cells could be due to the increases of other types of immune cells (Fig. 4g, h). These results together showed that IFNγ+ T cells could mediate P. zoogleoformans-induced aggravation of PH.
Cervical lymph nodes are crucial for the exacerbation of PH caused by P. zoogleoformans
cLNs play a crucial role in initiating immune responses to pathogenic antigens in the oral cavity. To elucidate their role in P. zoogleoformans-induced exacerbation of PH, cLN excision (CE) was performed in mice followed by ligation of molars and inoculation of P. zoogleoformans as well as induction of hypoxia (Fig. 5a). CE significantly inhibited the increases in RVSP and Fulton index induced by P. zoogleoformans, but had no effect on PH mice (Fig. 5b, c). Moreover, the decrease in PAT/PET ratio was reversed by cLN excision (Fig. 5d, and e). The size of cardiomyocytes in the PH + Pz group, but not PH group, was also markedly decreased by CE, suggesting the amelioration of P. zoogleoformans-enhanced right ventricle hypertrophy (Fig. S6a and S6b). Consistently, pulmonary artery remodeling was significantly alleviated after the excision of cLNs, as shown by the decreased medial thickness and smaller α-SMA+ area in the PH + Pz + CE group versus PH + Pz group (Fig. 5f–h). However, CE failed to alleviate pulmonary artery remodeling in PH mice (Fig. 5f–h). We next evaluated the effects of CE on the infiltration of IFNγ+ T cells in lungs of PH + Pz mice by flow cytometry. The removal of cLNs significantly suppressed CD4+ IFNγ+ T cell accumulation in the lungs, while it did not affect the numbers of CD8+ IFNγ+ T cells (Fig. 4a–d, 5i–k, S6c and S6d), indicating that the enriched CD4+ IFNγ+ T cells in lungs come from cLNs in PH + Pz mice. These results cumulatively demonstrated that cLNs were indispensable for P. zoogleoformans-induced exacerbation of PH and its associated cardiac and vascular remodeling.
IFNγ neutralization mitigates PH exacerbated by P. zoogleoformans
We next determined whether IFNγ induced by P. zoogleoformans was involved in the exacerbation of PH. For this purpose, mice were intraperitoneally injected with IFNγ neutralizing antibodies every three days during hypoxia exposure (Fig. 6a). Neutralization of IFNγ significantly decreased RVSP and the Fulton index of PH mice and PH + Pz mice (Fig. 6b, c). In addition, echocardiography demonstrated that neutralization of IFNγ improved PAT/PET ratio in PH mice and reversed the decrease of PAT/PET ratio induced by P. zoogleoformans (Fig. 6d, e). Similarly, the cardiomyocyte hypertrophy of RV was significantly reduced after IFNγ neutralization in the PH group and PH + Pz group, as shown by the WGA staining results (Fig. 6f, g). Moreover, blocking IFNγ ameliorated pulmonary vessel wall remodeling in PH mice and reversed the P. zoogleoformans-induced aggravation in vascular remodeling of pulmonary arteries, as shown by H&E and α-SMA staining (Fig. 6h–j). Thus, neutralization of IFNγ markedly reversed the effects of P. zoogleoformans on hypoxia-induced PH, emphasizing the crucial role of IFNγ.
Discussion
Multiple studies have shown that the oral microbiota could shape the pulmonary microbiota by invading the lungs, leading to lung dysfunction and an increase in proinflammatory cytokines, which are correlated with the progression of PH.18,24,30 Despite these observed associations, there is a notable lack of definite evidence linking the oral microbiota to the worsening of PH. In this study, a composite mouse model incorporating periodontitis and PH was used, and we showed for the first time that periodontitis exacerbated the progression of PH. Mechanistically, periodontitis fostered ectopic colonization of P. zoogleoformans in the lungs, upregulating the infiltration of IFNγ+ T cells and ultimately intensifying the severity of PH (Fig. 7).
Our data have clearly demonstrated that periodontitis exacerbates the progression of PH. In the current study, we focused on the role of periodontal disease, which is a paradigmatic manifestation of oral microbial dysbiosis, in the pathogenesis of PH. We observed that periodontitis promoted RV dysfunction and aggravated pulmonary arterial remodeling in hypoxia-induced PH. PH is a vasculopathy characterized by excessive pulmonary vasoconstriction and aberrant vascular remodeling processes, which involve uncontrolled proliferation of endothelial and smooth muscle cells, as well as fibroblasts.3,24 Interestingly, evidence from epidemiological studies suggests that individuals with periodontitis exhibit notable endothelial dysfunction, while periodontal treatment increases surrogate measures of endothelial function, such as flow-mediated dilation of the brachial artery.31,32 Additionally, numerous clinical studies have revealed that hypertensive individuals with periodontitis exhibit elevated blood pressure, and intensive periodontal treatment significantly reduces blood pressure.33,34 Although it has been reported that periodontitis adversely affects vascular function, there remains insufficient evidence clarifying the role of periodontitis in PH.35 Our study demonstrated that periodontitis significantly exacerbated PH, suggesting a direct connection between periodontitis and PH. Consequently, appropriate oral care, such as periodontal treatment, is a potentially effective strategy for addressing the comorbidity of periodontal disease and PH.
Periodontitis further worsens lung microbiota dysbiosis caused by PH through the oral-lung axis, potentially contributing to the further aggravation of PH. Accumulating evidence suggests that alterations in the airway microbiota have vital effects on the progression of PH.7 Our findings showed that periodontitis not only increased microbial diversity but also altered the composition of the lung microbiota during PH. Consistent with a previous study, Ralstonia, which was as a major genus in oropharynx respiratory tract microorganism samples of PH patients, was also the predominant genus in lung samples of the PH and PH + PD groups in our hypoxia-induced mouse model, indicating that the hypoxia-induced mouse model could mimic the changes in the pulmonary microbiota of patients with PH to some extent.10 More importantly, periodontitis promoted the enrichment of oral resident bacteria in the lungs, including P. zoogleoformans. These findings suggested that periodontitis may further exacerbate the preexisting microecological disorders associated with PH by facilitating the translocation of oral bacteria to the lungs. Correspondingly, previous findings revealed that periodontitis could not only induce oral microbiota dysbiosis but also affect distal organs/tissues, including atherosclerotic plaques, placenta, and lungs.35 Periodontitis has also been linked to alterations in the gut microbiota in humans and mice.36,37 While the oral microbiome is recognized as a contributing factor in various cardiovascular diseases, its connection to PH has received limited attention. Therefore, our data strengthen the evidence of microbial communication along the oral-lung axis, emphasizing its significance in the pathogenesis of PH in the context of poor periodontal health.
Periodontitis with oral inoculation of P. zoogleoformans contributes to the progression of hypoxia-induced PH. Through analysis of microbiota in the oral cavity and lungs, we identified the gram-negative bacterium P. zoogleoformans as a potential key contributor to the exacerbation of PH. Further experiments demonstrated that oral inoculation of P. zoogleoformans potentiated the response to chronic hypoxia in mice. These results highlighted the importance of the oral bacterium P. zoogleoformans, which likely worked through ectopic colonization in the lungs, in the exacerbation of PH by periodontitis. In fact, previous findings suggest that periodontal pathobionts can translocate via the oro-pharyngeal route, ectopically colonizing the lungs.22,38 Moreover, ectopically colonized periodontal pathogens from the oral cavity may modulate immune responses outside the oral cavity, contributing to systemic disease development.35,39–41 Similarly, a previous study has shown that airway delivery of S. salivarius induces experimental PH in rats, indicating the connections between the oral microbiota and PH.42 The combined findings of our study and previous research highlight that P. zoogleoformans can be remotely disseminated and trigger immune responses that actively contribute to its pathogenic potential. Considering the potential pathogenic role of P. zoogleoformans in PH, targeting P. zoogleoformans and preventing ectopic pulmonary colonization are promising strategies for the treatment of PH as a comorbidity of periodontitis.
P. zoogleoformans predominantly mobilized IFNγ+ T cells during PH. In the current study, we found that oral inoculation of P. zoogleoformans facilitated the infiltration of IFNγ+ T cells in the cLNs and lungs. Removal of cLNs abrogated the P. zoogleoformans-induced increase in the pulmonary infiltration of IFNγ+ T cells, especially CD4+ IFNγ+ T cells, indicating that CD4+ IFNγ+ T cells may migrate to the lungs from cLNs. Finally, we demonstrated that blocking IFNγ effectively limited the exacerbation of PH in mice after inoculation with P. zoogleoformans, suggesting that P. zoogleoformans aggravated PH in an IFNγ-dependent manner. Previous studies have shown that knockout of IFNγ in mice reverses PH caused by Pneumocystis infection,43 indicating the crucial role of this cytokine in the development of PH. Furthermore, increased IFNγ levels in the plasma and lungs have been observed in patients with various types of PH, and a rare but extremely serious adverse effect of clinical interferon treatment is PH.41,44–48 In light of these findings and our results, it can be inferred that blocking IFNγ is beneficial for treating PH.
Collectively, our results demonstrated a direct relationship between periodontitis and PH. Mechanistically, oral bacterium P. zoogleoformans promoted pulmonary inflammation, subsequently contributing to the pathogenesis of PH via IFNγ. These findings suggest that targeting periodontitis or P. zoogleoformans holds promise for refining the precision of PH treatment, and that IFNγ is a promising therapeutic target of PH especially as a comorbidity of periodontitis.
Materials and methods
Mice
Eight-week-old male C57BL/6 mice (weight 23–25 g) were obtained from Beijing Vital River Laboratories (Beijing, China) and housed in a standard environment (23 °C; 12/12-h light/dark cycle) with ad libitum access to water and food at an SPF facility. To establish a consistent commensal microbiota, mice from different cages were cross-housed on soiled bedding for 2 weeks before the experiments. Ethics approval for all animal studies was granted by the Institute of Animal Care and Use Committee of Cyagen (Approval No. ACU21-A041; Cyagen Biosciences Inc.) and adhered to ARRIVE guidelines.
Animal experiments
Mice were randomly assigned to different groups, and then exposed to hypoxia (10% O2) for 3 weeks to establish PH or room air as a control. In IFNγ neutralization experiment, mice received intraperitoneal injections of 200 μg anti-IFNγ antibodies (BP0055, BioXcell) in 200 μL PBS every 3 days (seven doses in total) as previously described.49 Heart and lung samples were subjected to perfusion, fixation, and embedding for further analysis. The right lung was snap-frozen in nitrogen (N2) and stored at −80 °C.
Periodontitis was induced by bilateral ligation around the maxillary second molars.50,51 Subgingival plaque (PL) samples collected from patients with moderate to severe chronic periodontitis were centrifuged and resuspended in sterile 2% carboxymethylcellulose, and then orally inoculated (100 μL per mouse) once every two days for 2 weeks.52
For the Pz mouse model, periodontitis was induced by bilateral ligation around the maxillary second molars, and a total of 1 × 109|colony-forming units (CFU) of P. zoogleoformans in sterile 2% carboxymethylcellulose were orally inoculated (100 μL per mouse), once every two days for 2 weeks.
Mice in the control group and PH group were subjected to sham ligation and treated with 2% carboxymethylcellulose without bacteria. Oral ligatures were maintained throughout the experiments for the periodontal ligation groups or for 3 h before the end of experiments in the periodontal sham ligation groups.37 After the mice were sacrificed, the ligatures were collected and stored at -80 °C for subsequent microbiome analysis. Mouse maxillae were prepared for analysis after the removal of soft tissues, overnight bleaching with 3% hydrogen peroxide solution, and staining with 1% methylene blue aqueous solution.53
For the cLN excision surgery, a small incision was made on the skin overlying the salivary glands (the base of the left and right ear junctions) and the skin was separated from the underlying fascia. With the aid of a surgical microscope, cLNs around the salivary glands were removed.54
Echocardiographic assessment
Mice were anesthetized with 1.5% isoflurane and subjected to echocardiography with a 30 MHz probe (Vevo 3100LT, Visual Sonics, Ontario, Canada). Body temperature was maintained at 37 °C and heart rate was maintained at 500–550 beats per min. Pulse-wave Doppler echocardiography was used to record pulmonary blood outflow at the level of the aortic valve in short-axis view to measure PAT and PET. The sample volume was placed in the center of the color Doppler PA.55 Assessments including PAT and PET were performed using Visual Sonics Vevo 3100 analysis software (v.3.2.6) and averaged over 5 cardiac cycles.56
Hemodynamic and ventricular weight measurements
Mouse RVSP was monitored using radiotelemetry according to established methods.57,58 Mice were anesthetized and hearts were exposed between the fourth and fifth ribs with two blunt forceps. Pressure transmitter (HDX10, Data Sciences International) was inserted into the RV through a xiphocostal angle approach.59 Pressure was recorded every 10 s for 3–5 min. The RV was carefully isolated from the left ventricle (LV) using curved tenotomy scissors, and the septum (S) with the LV was retained. RV and (LV + S) were weighed, and the Fulton index was calculated as RV/(LV + S).
Histological analysis
Lungs and hearts were fixed with 4% paraformaldehyde for 24 h and embedded in paraffin. Sections (5 μm thick) were subjected to H&E staining. For immunofluorescence staining, antigen retrieval was performed by boiling the samples in citric acid buffer (pH 6.0) for 30 min. The sections were blocked in 5% goat serum for 60 min and incubated with primary antibodies (BM0002, Boster Biotech) at 4 °C overnight. This was followed by incubation with fluorochrome-conjugated secondary antibodies (Thermo Fisher Scientific) at room temperature for 2 h and DAPI (P36931, Thermo Fisher Scientific) counterstaining. WGA staining was performed at 37 °C in the dark for 2 h. Wall thickness in experimental PH models was assessed using vessels (<100 μm in diameter) and bronchial arteries were excluded. Wall thickness was calculated with the formula ((2×medial wall thickness/external diameter) ×100).59 The sections were inspected using a fluorescence microscope (Leica).
Fluorescent in situ hybridization
Formalin-fixed, paraffin-embedded lung tissues were de-waxed and sequentially immersed in ethanol. The sections were washed with sterile PBS and incubated with lysozyme buffer (7 mg/mL) at 37 °C for 20 min. After being pretreated with hybridization buffer (0.9 NaCl, 20 mmol/L Tris-Cl (pH 8), and 0.1% (wt/vol) SDS) at 48 °C for 20 min, the sections were incubated with hybridization buffer containing 25% formamide and 0.2 μmol/L Alexa Fluor 594-labeled P. zoogleoformans probe (5′-TCCTTTACGGTTACGCACTTC-3′) in a dark humid chamber at 48 °C for 2 h. The sections were then washed with hybridization washing solution (0.02 mol/L NaCl, 20 mmol/L Tris-Cl (pH 8), 0.5 mol//L EDTA and 0.1% (wt/vol) SDS) for 25 min at 48 °C.60,61 The sections were counterstained with DAPI (P36931, Thermo Fisher Scientific).
Bacterial growth
P. zoogleoformans (CCUG 20495 T) was cultured in chopped meat carbohydrate broth (HLM0052, Haling Biological Technology Co., Ltd) supplemented with hemin (0.5 mg) and vitamin K1 (5 mg) per 100 mL of broth. A. parvulum (CCUG 69363 A) was cultured on chocolate agar (HLM1802B, Haling Biological Technology Co., Ltd). S. mutans (UA159) was cultured in brain heart infusion (237500, BD Pharmingen) broth. All bacteria were grown anaerobically at 37 °C for 48 h. Bacterial DNA was extracted from a single colony, and the identity of individual isolates was verified by nearly full-length 16 S rRNA gene sequencing.
Microbiome analysis
DNA extraction from the oral ligatures and lungs was performed using OMEGA Soil DNA Kits (M5635-02, Omega). The bacterial 16 S rRNA gene was amplified by PCR using primers (27 F: 5′-AGAGTTTGATCCTGGCTCAG-3′, 1492 R: 5′-GGTTACCTTGTTACGACTT-3′) with sample-specific barcodes. PCR amplicons were purified, quantified, and sequenced. Microbiome bioinformatics was performed by QIIME software. The raw data have been submitted to the NCBI Short Read Archive under the BioProject accession number PRJNA1042941.
Immune cell analysis
For flow cytometry, single-cell suspensions of mouse cLNs and lungs were prepared according to published protocols.53,62 Red blood cells were removed by lysis buffer (00-4300-54, eBioscience). Single-cell suspensions were incubated with flow cytometry antibodies targeting surface markers. For intracellular cytokine staining, the suspensions were stimulated using Leukocyte Activation Cocktail with BD GolgiPlug (423303, Biolegend) for 5 h. Antibodies against CD45-BV510 (103137, Biolegend), CD3-FITC (553061, BD Pharmingen), CD4-BV421 (100543, Biolegend), CD8-PE-Cy7 (100721, Biolegend), IL-17A-PE (506903, Biolegend) and IFN-γ-APC (505809, Biolegend) were used at a 1:200 dilution ratio. Dead cells were excluded from analysis using the Zombie NIR™ Fixable Viability Kit (423106, Biolegend). Samples were analyzed using a BD LSRFortessa X-20 (BD Biosciences) or CytoFLEX (Beckman Coulter). Results were analyzed using FlowJo 10.5.3 software (BD Biosciences).
Statistical analysis
The data are presented as the mean ± SEM. Prism (GraphPad Software) was used for statistical analysis. Significant differences were evaluated by unpaired Student’s t test or two-way ANOVA. Kruskal‒Wallis test and PERMANOVA were used for microbiota α-diversity and β-diversity analysis. Values of P ≤ 0.05 were considered statistically significant.
Supplementary information
Acknowledgements
This research received fundings from the National Natural Science Foundation of China (82330015, 81991503, 81921002, and 82303275), Science and Technology Commission of Shanghai Municipality (23ZR1438300), Fundamental research program funding of Ninth People’s Hospital affiliated to Shanghai Jiao Tong University School of Medicine (JYZZ178), and the Opening Research Fund (2022SKLS-KFKT012) from Shanghai Key Laboratory of Stomatology, Shanghai Ninth People’s Hospital, College of Stomatology, Shanghai Jiao Tong University School of Medicine. We express our gratitude to Chen-Zhi Guo from the Core Facility of Basic Medical Sciences, Shanghai Jiao Tong University School of Medicine for invaluable assistance with flow cytometry.
Author contributions
Shengzhong Duan and Xiaoqian Meng conceived and designed the experiments. Xiaoqian Meng, Linjuan Du, Shuo Xu, Lujun Zhou, Boyan Chen, Yulin Li, Chumao Chen, Huilin Ye, Jun Zhang, Guocai Tian, Xuebing Bai, Ting Dong, Wenzhen Lin, Mengjun Sun, Kecong Zhou and Yan Liu executed the experiments. Xiaoqian Meng and Linjuan Du conducted the data analysis. Xiaoqian Meng, Wuchang Zhang, and Shengzhong Duan drafted and revised the manuscript. Shengzhong Duan and Wuchang Zhang cosupervised the study. All authors reviewed and approved the final manuscript.
Competing interests
The authors declare no conflicts of interest.
Footnotes
These authors contributed equally: Xiaoqian Meng, Linjuan Du
Contributor Information
Wuchang Zhang, Email: zhangwuchang104@hotmail.com.
Shengzhong Duan, Email: duansz2008@hotmail.com.
Supplementary information
The online version contains supplementary material available at 10.1038/s41368-024-00291-2.
References
- 1.Kylhammar D, et al. A comprehensive risk stratification at early follow-up determines prognosis in pulmonary arterial hypertension. Eur. Heart J. 2018;39:4175–4181. doi: 10.1093/eurheartj/ehx257. [DOI] [PubMed] [Google Scholar]
- 2.Frost, A. et al. Diagnosis of pulmonary hypertension. Eur. Respir. J.53, 10.1183/13993003.01904-2018 (2019). [DOI] [PMC free article] [PubMed]
- 3.Hassoun PM, Taichman DB. Pulmonary arterial hypertension. N. Engl. J. Med. 2021;385:2361–2376. doi: 10.1056/NEJMra2000348. [DOI] [PubMed] [Google Scholar]
- 4.Humbert M, et al. Sotatercept for the treatment of pulmonary arterial hypertension. N. Engl. J. Med. 2021;384:1204–1215. doi: 10.1056/NEJMoa2024277. [DOI] [PubMed] [Google Scholar]
- 5.Chen J, et al. Microbiome and metabolome dysbiosis of the gut-lung axis in pulmonary hypertension. Microbiol. Res. 2022;265:127205. doi: 10.1016/j.micres.2022.127205. [DOI] [PubMed] [Google Scholar]
- 6.Chen, Y. H., Yuan, W., Meng, L. K., Zhong, J. C. & Liu, X. Y. The role and mechanism of gut microbiota in pulmonary arterial hypertension. Nutrients14, 10.3390/nu14204278 (2022). [DOI] [PMC free article] [PubMed]
- 7.Huang L, Zhang H, Liu Y, Long Y. The role of gut and airway microbiota in pulmonary arterial hypertension. Front Microbiol. 2022;13:929752. doi: 10.3389/fmicb.2022.929752. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Oliveira SD. Insights on the gut-mesentery-lung axis in pulmonary arterial hypertension: a poorly investigated crossroad. Arterioscler. Thromb. Vasc. Biol. 2022;42:516–526. doi: 10.1161/ATVBAHA.121.316236. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Wu P, Zhu T, Tan Z, Chen S, Fang Z. Role of gut microbiota in pulmonary arterial hypertension. Front Cell Infect. Microbiol. 2022;12:812303. doi: 10.3389/fcimb.2022.812303. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Zhang C, et al. Altered airway microbiota composition in patients with pulmonary hypertension. Hypertension. 2020;76:1589–1599. doi: 10.1161/HYPERTENSIONAHA.120.15025. [DOI] [PubMed] [Google Scholar]
- 11.Kim S, et al. Altered gut microbiome profile in patients with pulmonary arterial hypertension. Hypertension. 2020;75:1063–1071. doi: 10.1161/HYPERTENSIONAHA.119.14294. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Karoor, V. et al. The short-chain fatty acid butyrate attenuates pulmonary vascular remodeling and inflammation in hypoxia-induced pulmonary hypertension. Int. J. Mol. Sci.22, 10.3390/ijms22189916 (2021). [DOI] [PMC free article] [PubMed]
- 13.Huang Y, et al. Gut microbial metabolite trimethylamine N-oxide aggravates pulmonary hypertension. Am. J. Respir. Cell Mol. Biol. 2022;66:452–460. doi: 10.1165/rcmb.2021-0414OC. [DOI] [PubMed] [Google Scholar]
- 14.Moutsoglou DM, et al. Pulmonary arterial hypertension patients have a proinflammatory gut microbiome and altered circulating microbial metabolites. Am. J. Respir. Crit. Care Med. 2023;207:740–756. doi: 10.1164/rccm.202203-0490OC. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Sanada TJ, et al. Gut microbiota modification suppresses the development of pulmonary arterial hypertension in an SU5416/hypoxia rat model. Pulmonary Circ. 2020;10:2045894020929147–2045894020929147. doi: 10.1177/2045894020929147. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Gaeckle NT, Pragman AA, Pendleton KM, Baldomero AK, Criner GJ. The oral-lung axis: the impact of oral health on lung health. Respir Care. 2020;65:1211–1220. doi: 10.4187/respcare.07332. [DOI] [PubMed] [Google Scholar]
- 17.Dong J, et al. Relationships between oral microecosystem and respiratory diseases. Front Mol. Biosci. 2021;8:718222. doi: 10.3389/fmolb.2021.718222. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Segal LN, et al. Enrichment of the lung microbiome with oral taxa is associated with lung inflammation of a Th17 phenotype. Nat. Microbiol. 2016;1:16031. doi: 10.1038/nmicrobiol.2016.31. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Mammen MJ, Scannapieco FA, Sethi S. Oral-lung microbiome interactions in lung diseases. Periodontol 2000. 2020;83:234–241. doi: 10.1111/prd.12301. [DOI] [PubMed] [Google Scholar]
- 20.Pu CY, Seshadri M, Manuballa S, Yendamuri S. The Oral Microbiome and Lung Diseases. Current Oral Health Reports. 2020;7:79–86. doi: 10.1007/s40496-020-00259-1. [DOI] [Google Scholar]
- 21.Hajishengallis G. Interconnection of periodontal disease and comorbidities: Evidence, mechanisms, and implications. Periodontol 2000. 2022;89:9–18. doi: 10.1111/prd.12430. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Hajishengallis, G. & Chavakis, T. Local and systemic mechanisms linking periodontal disease and inflammatory comorbidities. Nat Rev Immunol, 1-15, (2021). [DOI] [PMC free article] [PubMed]
- 23.Dorfmüller P, Perros F, Balabanian K, Humbert M. Inflammation in pulmonary arterial hypertension. European Respiratory Journal. 2003;22:358. doi: 10.1183/09031936.03.00038903. [DOI] [PubMed] [Google Scholar]
- 24.Schermuly RT, Ghofrani HA, Wilkins MR, Grimminger F. Mechanisms of disease: pulmonary arterial hypertension. Nat Rev Cardiol. 2011;8:443–455. doi: 10.1038/nrcardio.2011.87. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Wang R-R, et al. Immunity and inflammation in pulmonary arterial hypertension: From pathophysiology mechanisms to treatment perspective. Pharmacological Research. 2022;180:106238. doi: 10.1016/j.phrs.2022.106238. [DOI] [PubMed] [Google Scholar]
- 26.Rabinovitch M, Guignabert C, Humbert M, Nicolls MR. Inflammation and immunity in the pathogenesis of pulmonary arterial hypertension. Circ Res. 2014;115:165–175. doi: 10.1161/CIRCRESAHA.113.301141. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Ryan JJ, Archer SL. The right ventricle in pulmonary arterial hypertension: disorders of metabolism, angiogenesis and adrenergic signaling in right ventricular failure. Circ Res. 2014;115:176–188. doi: 10.1161/CIRCRESAHA.113.301129. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Tuder RM, Groves B, Badesch DB, Voelkel NF. Exuberant endothelial cell growth and elements of inflammation are present in plexiform lesions of pulmonary hypertension. Am. J. Pathol. 1994;144:275–285. [PMC free article] [PubMed] [Google Scholar]
- 29.Cool CD, Kennedy D, Voelkel NF, Tuder RM. Pathogenesis and evolution of plexiform lesions in pulmonary hypertension associated with scleroderma and human immunodeficiency virus infection. Hum. Pathol. 1997;28:434–442. doi: 10.1016/S0046-8177(97)90032-0. [DOI] [PubMed] [Google Scholar]
- 30.Zhang J, et al. Differential oral microbial input determines two microbiota pneumo-types associated with health status. Adv. Sci. (Weinh) 2022;9:e2203115. doi: 10.1002/advs.202203115. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Sanz M, et al. Periodontitis and cardiovascular diseases: consensus report. J. Clin. Periodontol. 2020;47:268–288. doi: 10.1111/jcpe.13189. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Herrera D, et al. Association between periodontal diseases and cardiovascular diseases, diabetes and respiratory diseases: Consensus report of the Joint Workshop by the European Federation of Periodontology (EFP) and the European arm of the World Organization of Family Doctors (WONCA Europe) J. Clin. Periodontol. 2023;50:819–841. doi: 10.1111/jcpe.13807. [DOI] [PubMed] [Google Scholar]
- 33.Czesnikiewicz-Guzik M, et al. Causal association between periodontitis and hypertension: evidence from Mendelian randomization and a randomized controlled trial of non-surgical periodontal therapy. Eur. Heart J. 2019;40:3459–3470. doi: 10.1093/eurheartj/ehz646. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Chen B-Y, et al. Roles of oral microbiota and oral-gut microbial transmission in hypertension. J. Adv. Res. 2023;43:147–161. doi: 10.1016/j.jare.2022.03.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Hajishengallis G. Periodontitis: from microbial immune subversion to systemic inflammation. Nat. Rev. Immunol. 2015;15:30–44. doi: 10.1038/nri3785. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Lourenςo TGB, Spencer SJ, Alm EJ, Colombo APV. Defining the gut microbiota in individuals with periodontal diseases: an exploratory study. J. Oral Microbiol. 2018;10:1487741. doi: 10.1080/20002297.2018.1487741. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Kitamoto, S. et al. The Intermucosal Connection between the Mouth and Gut in Commensal Pathobiont-Driven Colitis. Cell, 10.1016/j.cell.2020.05.048 (2020). [DOI] [PMC free article] [PubMed]
- 38.Bui FQ, et al. Association between periodontal pathogens and systemic disease. Biomed. J. 2019;42:27–35. doi: 10.1016/j.bj.2018.12.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Shen, X. et al. Ectopic colonization and immune landscapes of periodontitis microbiota in germ-free mice with streptozotocin-induced type 1 diabetes mellitus. Front. Microbiol.13, 10.3389/fmicb.2022.889415 (2022). [DOI] [PMC free article] [PubMed]
- 40.Atarashi K, et al. Ectopic colonization of oral bacteria in the intestine drives T(H)1 cell induction and inflammation. Science. 2017;358:359–365. doi: 10.1126/science.aan4526. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Blasco-Baque V, et al. Periodontitis induced by Porphyromonas gingivalis drives periodontal microbiota dysbiosis and insulin resistance via an impaired adaptive immune response. Gut. 2017;66:872–885. doi: 10.1136/gutjnl-2015-309897. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Zhang C, et al. Airway delivery of Streptococcus salivarius is sufficient to induce experimental pulmonary hypertension in rats. Br. J. Pharmacol. 2023;180:2102–2119. doi: 10.1111/bph.16064. [DOI] [PubMed] [Google Scholar]
- 43.Swain SD, Siemsen DW, Pullen RR, Han S. CD4+ T cells and IFN-γ are required for the development of pneumocystis-associated pulmonary hypertension. Am. J. Pathol. 2014;184:483–493. doi: 10.1016/j.ajpath.2013.10.027. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Tomaszewski, M. et al. Overexpression of PD-1 on peripheral blood lymphocytes in patients with idiopathic pulmonary arterial hypertension and its association with high viral loads of epstein-barr virus and poor clinical parameters. J. Clin. Med.9, 10.3390/jcm9061966 (2020). [DOI] [PMC free article] [PubMed]
- 45.Li S, Ma X, Xie J, Yan X, Sun W. MicroRNA-206, IL-4, IL-13, and INF-γ levels in lung tissue and plasma are increased by the stimulation of particulate matter with a diameter of ≤2.5 μm, and are associated with the poor prognosis of asthma induced pulmonary arterial hypertension patients. Clin. Experimental Hypertension. 2021;43:181–188. doi: 10.1080/10641963.2020.1836192. [DOI] [PubMed] [Google Scholar]
- 46.Liu, S.-F. et al. Pulmonary hypertension: Linking inflammation and pulmonary arterial stiffening. Front. Immunol.13, 10.3389/fimmu.2022.959209 (2022). [DOI] [PMC free article] [PubMed]
- 47.George PM, et al. Evidence for the involvement of type I interferon in pulmonary arterial hypertension. Circ. Res. 2014;114:677–688. doi: 10.1161/CIRCRESAHA.114.302221. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Papani R, Duarte AG, Lin YL, Kuo YF, Sharma G. Pulmonary arterial hypertension associated with interferon therapy: a population-based study. Multidiscip. Respir. Med. 2017;12:1. doi: 10.1186/s40248-016-0082-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Glasner A, et al. NKp46 receptor-mediated interferon-γ production by natural killer cells increases fibronectin 1 to alter tumor architecture and control metastasis. Immunity. 2018;48:107–119.e104. doi: 10.1016/j.immuni.2017.12.007. [DOI] [PubMed] [Google Scholar]
- 50.Ma XX, et al. Ncor1 deficiency promotes osteoclastogenesis and exacerbates periodontitis. J. Dent. Res. 2023;102:72–81. doi: 10.1177/00220345221116927. [DOI] [PubMed] [Google Scholar]
- 51.Abe T, Hajishengallis G. Optimization of the ligature-induced periodontitis model in mice. J. Immunol. Methods. 2013;394:49–54. doi: 10.1016/j.jim.2013.05.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Bai, L., Chen, B.-Y., Liu, Y., Zhang, W.-C. & Duan, S.-Z. A mouse periodontitis model with humanized oral bacterial community. Front. Cell. Infect. Microbiol.12, 10.3389/fcimb.2022.842845 (2022). [DOI] [PMC free article] [PubMed]
- 53.Zhou LJ, et al. Oral pathobionts promote MS-like symptoms in mice. J. Dental Res. 2022;102:217–226. doi: 10.1177/00220345221128202. [DOI] [PubMed] [Google Scholar]
- 54.van Zwam M, et al. Surgical excision of CNS‐draining lymph nodes reduces relapse severity in chronic‐relapsing experimental autoimmune encephalomyelitis. J. Pathol. 2008;217:543–551. doi: 10.1002/path.2476. [DOI] [PubMed] [Google Scholar]
- 55.Zhu Z, et al. Echocardiographic assessment of right ventricular function in experimental pulmonary hypertension. Pulm Circ. 2019;9:2045894019841987. doi: 10.1177/2045894019841987. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Thibault HB, et al. Noninvasive assessment of murine pulmonary arterial pressure. Circ.: Cardiovas. Imaging. 2010;3:157–163. doi: 10.1161/CIRCIMAGING.109.887109. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Du L-J, et al. NCOR1 maintains the homeostasis of vascular smooth muscle cells and protects against aortic aneurysm. Cell Death Differ. 2022;30:618–631. doi: 10.1038/s41418-022-01065-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Handoko ML, et al. A refined radio-telemetry technique to monitor right ventricle or pulmonary artery pressures in rats: a useful tool in pulmonary hypertension research. Pflugers Arch. 2008;455:951–959. doi: 10.1007/s00424-007-0334-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Shu T, et al. Inhibition of immunoglobulin E attenuates pulmonary hypertension. Nat. Cardiovas. Res. 2022;1:665–678. doi: 10.1038/s44161-022-00095-9. [DOI] [PubMed] [Google Scholar]
- 60.Dong T, et al. Prevotella intermedia aggravates subclinical hypothyroidism. J. Dental Res. 2023;102:814–824. doi: 10.1177/00220345231168052. [DOI] [PubMed] [Google Scholar]
- 61.Nejman D, et al. The human tumor microbiome is composed of tumor type–specific intracellular bacteria. Science. 2020;368:973–980. doi: 10.1126/science.aay9189. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62.Jungblut M, Oeltze K, Zehnter I, Hasselmann D, Bosio A. Standardized preparation of single-cell suspensions from mouse lung tissue using the gentleMACS Dissociator. J. Vis. Exp. 2009 doi: 10.3791/1266. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.